Glycemic and weight control in people with type 2 diabetes: A real-world observational study in primary care.

Autor: Orozco-Beltran D; Spanish Diabetes Society, Primary Care working group, Spain; Clinical Medicine Department, School of Medicine, Miguel Hernández University, Ctra. Nacional N-332 s/n, San Juan de Alicante 03550, Spain; Primary Care Research Center, Miguel Hernandez University, San Juan de Alicante, Spain; Research Network on Chronicity, Primary Care, and Health Promotion (RICAPPS), Spain., Mata-Cases M; Spanish Diabetes Society, Primary Care working group, Spain; DAP-Cat group, Research Support Unit Barcelona, Foundation University Institute for Primary Health Care Research Jordi Gol y Gurina (IDIAPJGol), Barcelona, Spain; Biomedical Research Networking Center in Diabetes and Associated Metabolic Disorders (CIBERDEM), Carlos III Health Institute (ISCIII), Barcelona, Spain., Artola-Menéndez S; Spanish Diabetes Society, Primary Care working group, Spain; José Marvá Health Center, Madrid. Primary Care Diabetes Study Groups Network (RedGDPs) Foundation, Spain., Álvarez-Guisasola F; Spanish Diabetes Society, Primary Care working group, Spain; Ribera del Órbigo Health Center, Family and Community Care Teaching Unit, Biosanitary Research Institute (IBIOLEÓN), León, Spain., Cebrián-Cuenca AM; Spanish Diabetes Society, Primary Care working group, Spain; Cartagena Casco Health Center, Primary Care Research Group, Biomedical Research Institute of Murcia, Cartagena, Spain. Electronic address: anicebrian@gmail.com., Pérez A; Endocrinology and Nutrition Service, Santa Creu i Sant Pau Hospital, Autonomous University of Barcelona, Barcelona, Spain; Biomedical Research Networking Center in Diabetes and Associated Metabolic Disorders (CIBERDEM), Carlos III Health Institute (ISCIII), Barcelona, Spain; Spanish Diabetes Society, Former President, Spain.
Jazyk: angličtina
Zdroj: Primary care diabetes [Prim Care Diabetes] 2024 Dec 30. Date of Electronic Publication: 2024 Dec 30.
DOI: 10.1016/j.pcd.2024.12.002
Abstrakt: Aims: To analyze glycemic and bodyweight control in people with type 2 diabetes mellitus (T2DM), and prescribing patterns in primary care.
Methods: We reviewed the electronic medical records of 5009 randomly selected T2DM patients, from 70 health centers in Spain. We analyzed results by age group and presence/absence of obesity. All data were collected in 2022.
Results: Regarding treatment, 13.2 % of the sample were on lifestyle therapy only, 76.5 % received metformin, 37.6 % SGLT2 inhibitors, 32.2 % DPP-4 inhibitors, 12.2 % GLP-1 agonists, 18.9 % insulin, 6.5 % sulfonylureas, and 1.3 % glitazones. Glycated Hemoglobin (HbA1c) was below 7 % in 57.7 % of patients, and 62.3 % met their individualized HbA1c targets. Overall, 42 % of the population was obese (45.6 % of women vs 39.1 % of men; p = 0.001). Obesity rates decreased with age in both sexes. We found no association between obesity and poor glycemic control (HbA1c<7 %) (43,5 % vs 41,4 %; p = 0,17).
Conclusions: In 2022, over 60 % of people with T2DM treated by family doctors in Spain met their individualized glycemic control targets, but only one in three had good glycemic control without obesity. The use of drugs with cardiorenal benefits (particularly SGLT2 inhibitors) is higher than previous published data in our setting.
Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. The author is an Associate Editor for [Primary Care Diabetes Journal] and was not involved in the editorial review or the decision to publish this article.
(Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: